Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-13T05:17:07.268Z Has data issue: false hasContentIssue false
  • English
  • Français

Cisplatin-albumin complex for treatment of cancer of the head and neck

Published online by Cambridge University Press:  29 June 2007

G. C. M. Vreeburg ,
P. M. Stell ,
J. D. Holding  and
W. E. Lindup
G. C. M. Vreeburg
Affiliation:
Departments of Otorhinolaryngology, University of Liverpool.
P. M. Stell
Affiliation:
Departments of Otorhinolaryngology, University of Liverpool.
J. D. Holding
Affiliation:
Departments of Pharmacology & Therapeutics, University of Liverpool.
W. E. Lindup*
Affiliation:
Departments of Pharmacology & Therapeutics, University of Liverpool.
*
Department of Pharmacology & Therapeutics, University of Liverpool, P.O. Box 147, Liverpool L69 3BX.
Get access Rights & Permissions [Opens in a new window]

Abstract

Many patients with cancer of the head and neck are unable to receive or continue treatment with cisplatin, which is nephrotoxic, because of poor renal function. We present here, however, the case of a patient who underwent conventional cisplatin therapy but who then had to be withdrawn from treatment because of renal toxicity despite having undergone partial remission. Treatment was then changed to cisplatin in the form of a cisplatin-albumin complex which is not nephrotoxic. The patient went on to a histologically confirmed complete response and we suggest that although the cisplatin-albumin complex may not be as effective as the conventional form of the drug it offers a possible form of treatment of patients with compromised renal function who could not otherwise be treated.

Keywords

Head and neck neoplasmsCisplatin, cisplatin albumin complex
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 106 , Issue 9 , September 1992 , pp. 832 - 833
Copyright
Copyright © JLO (1984) Limited 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cummings, J., Willmott, N., Marley, E., Smyth, J. (1991) Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition. Biochemical Pharmacology, 41: 1849–1854.CrossRefGoogle Scholar
DeSimone, P. A., Brennan, L., Cattaneo, M. L., Zucca, E. (1987) Phase I evaluation and pharmacokinetics of cisplatin (Cis Pt) complexed to albumin (Cisp Pt A). Proceedings of the American Society for Clinical Oncology, 6: abstract number 127.Google Scholar
Gerlowski, L., Jain, R. K. (1986) Microvascular permeability of normal and neoplastic tissues. Microvascular Research, 31: 288–305.CrossRefGoogle ScholarPubMed
Holding, J. D., Lindup, W. E., Van Laer, C, Vreeburg, G. C. M., Schilling, V., Wilson, J. A., Stell, P. M. (1992) Phase 1 trial of a cisplatin-albumin complex for treatment of cancer of the head and neck. British Journal of Clinical Pharmacology, 33: 75–81.Google Scholar
Lindup, W. E. (1987) Plasma protein binding of drugs—some basic and clinical aspects. In Progress in Drug Metabolism, 10: [Bridges, J. W., Chasseaud, L. R.Gibson, G. G., eds.] Taylor and Francis, London, p. 141–185.Google Scholar
Lindup, W. E., Holding, J. D., Van Laer, C., Stell, P. M. (1990) Phase 1 trial of cisplatin-albumin complex in the treatment of cancer of the head and neck. European Journal of Pharmacology, 183: 240–241.CrossRefGoogle Scholar
Morton, R. P., Rugman, R., Stell, P. M. (1985) Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomized factorial phase III controlled trial. Cancer Chemotherapy and Pharmacology, 15: 283–289.CrossRefGoogle ScholarPubMed
Taylor, S. G. (1987) Head and neck cancer. In Cancer Chemotherapy. [Pinedo, H. M. and Chabner, B. A., eds.] Vol. 7, Elsevier: Amsterdam, p. 287–301.Google Scholar
Uozumi, J., Litterst, C. L. (1988) The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats. Journal of Pharmacobiodynamics, 11: 277–283.CrossRefGoogle ScholarPubMed